Valuation: Gland Pharma Limited

Market Cap 425B 4.46B 3.87B 3.62B 3.32B 6.26B 6.37B 42.65B 16.71B 212B 16.75B 16.38B 699B P/E 2027 *
34.1x
P/E 2028 * 27.8x
Enterprise Value 388B 4.07B 3.54B 3.3B 3.03B 5.72B 5.82B 38.97B 15.26B 194B 15.3B 14.96B 639B EV / Sales 2027 *
5.3x
EV / Sales 2028 * 4.55x
Free-Float
48.23%
Yield 2027 *
0.76%
Yield 2028 * 0.83%
1 day+1.00%
1 week+7.27%
Current month+4.08%
1 month+5.75%
3 months+43.48%
6 months+37.85%
Current year+51.27%
1 week 2,428.7
Extreme 2428.7
2,610
1 month 2,351.1
Extreme 2351.1
2,610
Current year 1,573.6
Extreme 1573.6
2,610
1 year 1,573.6
Extreme 1573.6
2,610
3 years 1,277.8
Extreme 1277.8
2,610
5 years 861
Extreme 861
4,350
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap.
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+1.04%+7.27%+31.37%+95.06% 4.46B
-2.39%-6.36%+47.10%+149.66% 1T
-0.76%-4.34%+52.04%+49.09% 613B
-2.33%-4.60%+25.55%+64.44% 433B
+0.68%-1.14%+38.47%+33.36% 350B
-1.66%-3.13%+32.18%+39.79% 292B
-8.96%-10.77%+3.57%+5.50% 239B
-1.37%-7.41%-2.10%-43.67% 206B
-1.63%+0.69%+27.62%+64.23% 204B
+0.72%+0.48%+15.88%+73.64% 163B
Average -1.28%-2.86%+27.17%+53.11% 350.49B
Weighted average by Cap. -0.93%-4.33%+34.73%+70.99%

Financials

2027 *2028 *
Net sales 73.22B 768M 668M 623M 572M 1.08B 1.1B 7.35B 2.88B 36.52B 2.89B 2.82B 120B 83.28B 874M 759M 709M 651M 1.23B 1.25B 8.36B 3.27B 41.53B 3.28B 3.21B 137B
Net income 12.48B 131M 114M 106M 97.5M 184M 187M 1.25B 490M 6.22B 492M 481M 20.52B 15.31B 161M 140M 130M 120M 226M 230M 1.54B 602M 7.63B 603M 590M 25.18B
Net Debt -36.72B -385M -335M -313M -287M -541M -550M -3.69B -1.44B -18.31B -1.45B -1.41B -60.39B -46.04B -483M -420M -392M -360M -678M -690M -4.62B -1.81B -22.96B -1.81B -1.77B -75.73B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-08-04 2,606.00 +1.04% 158,047
26-08-03 ₹2,579.20 +3.05% 502,554
26-07-31 ₹2,502.90 -0.56% 266,828
26-07-30 ₹2,517.00 -1.05% 745,911
26-07-29 ₹2,543.70 +4.75% 841,656
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,579.20INR
Average target price
2,325.29INR
Spread / Average Target
-9.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock